The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

EMLA 5% w/w Cream

Aspen Pharma Trading LimitedPA1691/023/001

Main Information

Trade NameEMLA 5% w/w Cream
Active SubstancesLidocaine
Dosage FormCream
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/023/001

Group Information

ATC CodeN01BB Amides
N01BB20 combinations


License statusAuthorised
Licence Issued08/09/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back